- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT00578162
A Study of Survivorship Service Capacities Among Health Care Agencies in New York City
To describe the range of services available to cancer survivors in the NYC area.
To determine organizations' need for assistance to enhance services for survivors.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
To describe the range of services available to cancer survivors in the NYC area.
To determine organizations' need for assistance to enhance services for survivors.
Tipo di studio
Contatti e Sedi
Luoghi di studio
-
-
New York
-
New York, New York, Stati Uniti, 10065
- Memorial Sloan-Kettering Cancer Center
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Bambino
- Adulto
- Adulto più anziano
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
To be eligible to participate in the study, an agency must:
Be a current provider of either:
- General health services (GHS), such as primary care, health education and wellness, mental health services, home health care, palliative care, or cancer screening and diagnosis;
- Cancer-specific medical treatments (CMT), such as cancer surgery, radiation, chemotherapy, hormonal therapy; experimental therapies; cancer pain and symptom management; rehabilitation services; post-treatment monitoring and surveillance; or prophylactic treatments, such as chemoprevention; or
- Any type of specialized 'post-cancer' or 'after-cancer' medical care or support services (SMC) (i.e., psychotherapeutic, relationship and family, psycho-educational,wellness and quality of life)
- Be located within the five boroughs of New York City
- Have been serving cancer patients for 12 months or longer, and
- Be willing and able to identify an English-speaking representative, 21 years of age or older as its designated key informant.
Exclusion Criteria:
- We will limit this study to provider agencies such as hospitals, diagnostic centers, clinics, health and human service agencies, and grassroots community organizations and public service settings that offer programs for cancer survivors. Independent practitioners or private practice settings will not be surveyed. Our survey questions are intended for major health services organizations and are not appropriate for private practices settings.
We will use our screening questionnaire to determine where or not a given agency should be included or excluded from the study AGENCY SCREENER.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Coorti e interventi
Gruppo / Coorte |
Intervento / Trattamento |
---|---|
1
Data about participating agencies will be collected by electronic survey.
Agencies will be identified using the NYSDOH's existing mailing list of care facilities located in the five boroughs of New York City, referral databases and resource guides created by the American Cancer Society (ACS), the New York Hospital Directory.
|
A cancer care facility or 'agency' is the study's unit of analysis.
Data about participating agencies will be collected by electronic survey.
Agencies will be identified using the NYSDOH's existing mailing list of care facilities located in the five boroughs of New York City, referral databases and resource guides created by the American Cancer Society (ACS), the New York Hospital Directory
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Lasso di tempo |
---|---|
To determine agencies' need for assistance to enhance services for survivors.
Lasso di tempo: 2 years
|
2 years
|
Collaboratori e investigatori
Collaboratori
Investigatori
- Investigatore principale: David Loundsbury, PhD, Memorial Sloan Kettering Cancer Center
Pubblicazioni e link utili
Collegamenti utili
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
- 05-048
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Tutti i tumori
-
M.D. Anderson Cancer CenterSospesoCancro polmonare a piccole cellule | Linfoma di Hodgkin | Carcinoma cervicale | Mesotelioma peritoneale | Mesotelioma pleurico | Carcinomi neuroendocrini | Microsatellite High Cancers | Alto grado extrapolmonareStati Uniti